BackCompass Therapeutics Overview

Compass Therapeutics Long Term Debt

Track Compass Therapeutics's long-term debt ($8.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$8.42M
↑ 34.22% YoYΔ $2.15M vs prior year quarter

Peer average

Loading

Compass Therapeutics Long Term Debt History

Loading

Compass Therapeutics vs. peers: Long Term Debt Comparison

Loading

Compass Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Compass Therapeutics (CMPX) FAQ

Compass Therapeutics (CMPX) currently reports a long-term debt of $8.4M as of March 2026. That compares with $6.3M in the prior-year period — up 34.2% year over year. Use the charts on this page to explore Compass Therapeutics's long-term debt history and peer comparisons.

Compass Therapeutics's long-term debt increased from $6.3M to $8.4M — a 34.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Compass Therapeutics reported $8.4M in long-term debt as of March 2026. That compares with $6.3M in the prior-year period — up 34.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $8.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Compass Therapeutics, and consider following CMPX for alerts when major investors trade the stock.

Compass Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $8.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMPX with unrelated industries.